Pediatrix Medical (MD) EV to EBIT (2009 - 2026)

Pediatrix Medical (MD) has reported EV to EBIT for 18 consecutive years, with 29.04 the latest figure, recorded in Q2 2026.

• On a quarterly basis, EV to EBIT rose 93.61% year-over-year to 29.04 in Q2 2026; TTM through Jun 2026 was 7.67, a 41.07% increase from a year earlier, with the FY2025 full-year figure at 6.11, up 153.93% from the prior year.
• EV to EBIT was 29.04 for Q2 2026 at Pediatrix Medical, down from 34.24 in the prior quarter.
• Over five years, EV to EBIT peaked at 49.87 in Q1 2022 and troughed at 5.41 in Q4 2023.
• A 5-year average of 25.3 and a median of 26.47 in 2025 frame the typical range for EV to EBIT.
• Across the five-year window, EV to EBIT tumbled 117.27% in 2023 and jumped 560.08% in 2025, its largest moves.
• Over 5 years, EV to EBIT stood at 31.34 in 2022, then plunged by 117.27% to 5.41 in 2023, then soared by 465.75% to 19.8 in 2024, then surged by 31.97% to 26.13 in 2025, then gained by 11.13% to 29.04 in 2026.
• The last three EV to EBIT figures came in at 29.04 (Q2 2026), 34.24 (Q1 2026), and 26.13 (Q4 2025), per Business Quant data.